Lubar & Co’s AbbVie ABBV Stock Holding History

Lubar & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2,597	Closed	-$133K	–	14
2014 Q1	$133K	Sell	2,597 -4,017	-61%	-$203K	0.11%	31
2013 Q4	$349K	Hold	6,614	–	–	0.27%	33
2013 Q3	$296K	Buy	6,614 +2,597	+65%	+$115K	0.28%	34
2013 Q2	$166K	Buy	+4,017	New	+$176K	0.17%	35

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Lubar & Co's ABBV Position: Q2 2014 in Review

Lubar & Co sold out of AbbVie (ABBV) in Q2 2014, closing a stake of 2,597 shares — an estimated $133K sold.

Lubar & Co first reported a position in ABBV in Q2 2013 and held it in 4 quarters. The position peaked at $349K in Q4 2013. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Lubar & Co reported no remaining AbbVie position as of Q2 2014 after selling out during the quarter.
Lubar & Co sold 2,597 AbbVie shares in Q2 2014, an estimated $133K.
Lubar & Co first reported a position in AbbVie in Q2 2013 and held it in 4 quarters.
Lubar & Co's AbbVie position peaked at $349K in Q4 2013.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Lubar & Co's 13F filing for Q2 2014, filed 13 Aug 2014.